- Home
- MMED vs CRNX Comparison
MMED vs CRNX Comparison
Compare MMED & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$15.75
HOLD
Current Price
$37.22
Company Overview
Basic Information| Metric | MMED | CRNX |
|---|---|---|
| Founded | 1983 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.5B |
| IPO Year | 2026 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MMED | CRNX |
|---|---|---|
| Price | $15.75 | $37.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $74.78 |
| AVG Volume (30 Days) | N/A | ★ 846.2K |
| Earning Date | N/A | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,039,000.00 |
| Revenue This Year | N/A | $730.30 |
| Revenue Next Year | N/A | $179.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | N/A | $24.10 |
| 52 Week High | N/A | $57.99 |
Technical Indicators
Market Signals| Indicator | MMED | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 28.99 |
| Support Level | N/A | $33.23 |
| Resistance Level | N/A | $45.32 |
| Average True Range (ATR) | 0.00 | 1.85 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 0.00 | 19.04 |
Price Performance
Historical Comparison MMED
CRNX
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.